Learning Objectives: Mortality has been reported to be as high as 50% in patients presenting to the emergency department (ED) with sepsis, severe sepsis, or septic shock. The clinical pharmacist in the ED plays an instrumental role in providing appropriate dosing and empiric therapy recommendations for management of these patients. The Surviving Sepsis Campaign Guidelines recommend administrati...

BACKGROUND Patient satisfaction with medication therapy management (MTM), a required component of the Medicare Part D benefit, is an important outcome to consider when evaluating MTM programs. OBJECTIVE To measure patient satisfaction with a pharmacist-provided telephone MTM program. METHODS The study design was nonexperimental and cross sectional. A survey was mailed to Scott & White Healt...

BACKGROUND Supplementary prescribing (SP) is a drug therapy management model implemented in the United Kingdom since 2003. It is a voluntary partnership between an independent prescriber; a supplementary prescriber, for example, nurse or pharmacist; and the patient, to implement an agreed patient-specific clinical management plan (CMP). OBJECTIVE To investigate pharmacist prescribers' views a...

T he doctor is usually seen as a picture of never-ending optimism and incredible patience. Doctor themselves admit that their fraternity makes the worst patients. Th ey are diffi cult to handle, behave abnormally and keep brooding about complications that can happen and most of the time. In short it can be said that " doctors are the worst patient ". [1] But did pharmacist also suff er the same...

Objective: We used MEDMARX, the national medication error-reporting program, to compare medication errors reported by critical access hospitals (CAHs) to those reported by non-Federal, general community hospitals. Methods: We used the availability of pharmacist support to represent the structure and process of medication use and within-cluster resampling to account for the correlation of error ...

Methods We developed an AMS program, headed by a pharmacist and infectious diseases (ID) physician. Drug utilization reviews identified an expensive, broad-spectrum agent (piperacillin-tazobactam [P-T]) for initial targeting. An AMS form for listing clinical data and recommendations was developed. A daily list of patients receiving P-T was used to identify target patients for intervention. The ...

backgrounds : drug related problems can be defined as any event (or) circumstance involving the drug treatment, which interferes or potentially interferes with the patient in achieving an optimum outcome of medical care. the aim of the study was to identify drug therapy problems and to assess the pharmacist interventions in patients with cardiovascular diseases. methods: the inpatient case reco...